Popular
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
CME/CENo Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Brendon Neuen, MBBS, PhD
Katherine Tuttle, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Alireza Atri, MD, PhD
Raymond Scott Turner, MD, PhD
Dani Cabral, MD
Mechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
CME/CEMechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
MinuteCE®ELEVATE: Elacestrant Plus Capivasertib in Advanced Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Ongoing Trials in Oral Targeted Strategies in Breast Cancer
MinuteCE®Ongoing Trials in Oral Targeted Strategies in Breast Cancer
Aditya Bardia, MD, MPH, FASCO
Programs
No Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
CME/CENo Patient With CKD Left Behind: New Horizons in Patients With CKD Regardless of Diabetes Status
Brendon Neuen, MBBS, PhD
Katherine Tuttle, MD
Chairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
CME/CEChairperson’s Perspective: Reframing First-Line and Subsequent Care in Advanced Urothelial Carcinoma – Clinical Implications of the Updated NCCN Guidelines
Jean Hoffman-Censits, MD
Mechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
CME/CEMechanism to Match: Choosing the Right VMAT2 Strategy for the Patient
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Chairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
CME/CEChairperson’s Perspective: HER2 in Solid Tumors – From Pathology to Personalized Treatment Plans
Kathleen N. Moore, MD, MS
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CECracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Two Lenses on Migraine: Managing Incomplete Acute Treatment Response
Innovations In MedicineTwo Lenses on Migraine: Managing Incomplete Acute Treatment Response
Fallon Schloemer, DO
Susan Hutchinson, MD
Clinical Practice
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart MattersHypertension in Women: Cardiovascular Risk Across the Lifespan
Shelina Ramnarine, PhD
Payal Kohli, MD, FACC
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Making the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
CME/CEMaking the Right Moves in Metastatic CSPC: Intensification, Imaging, and Impact
Neeraj Agarwal, MD, FASCO
Rana McKay, MD
Ana’s Story – A Real Patient Living With Ulcerative Colitis
Medical Industry FeatureAna’s Story – A Real Patient Living With Ulcerative Colitis
Ana, A Real Patient Living With Ulcerative Colitis
Lukasz Kwapisz, MD
Closing the Gaps: Global Implementation of Lipid Guidelines
CME/CEClosing the Gaps: Global Implementation of Lipid Guidelines
Lina Badimón, MD, PhD
Michelle O’Donoghue, MD, MPH
Erin Michos, MD, MHS
Pam R. Taub, MD
Doctors Lounge
Brian P. McDonough, MD, FAAFP
Raja-Elie E. Abdulnour, MD
Jean-Claude Saghbini
“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
The Convergence“We have the opportunity to understand what happens when someone leaves the clinic,” says Dr. Rajiv Kumar of Apple and Stanford Medicine
Brian P. McDonough, MD, FAAFP
Rajiv Kumar, MD
Rehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
MAPSChatsRehumanizing Healthcare with AI: Turning Data Into Meaningful Outcomes
Matt Birnholz, MD
Dr. Susanna Gallani
Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
MAPSChatsInside Medical Affairs: MSL Insights on AI, Strategy, and Impact
Matt Birnholz, MD
Brandon Young, PhD
"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
The Convergence"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
Brian P. McDonough, MD, FAAFP
Michal Nedoszytko, MD
The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal CancerThe Changing Landscape of CRC Screening and Prevention
Ryan Quigley
Samuel Muench, MD
CME
Simple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
CME/CESimple Diagnostic Steps That Change TD Outcomes & Increase Quality of Life
Karen E. Anderson, MD
Hubert H. Fernandez, MD
Moving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
CME/CE Broadcast ReplayMoving Beyond Sleep: The Broader Connection Between the Orexin System and Psychiatric Disorders
Roger McIntyre, MD
Emmanuel Mignot, MD, PhD
AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
CME/CEAACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
Susan L Samson, MD, PhD, FRCPC, FACE
Lawrence Blonde, MD, FACP, FACE
Chairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
CME/CEChairperson’s Perspective: Incorporating Novel Treatment Options for Schizophrenia Into Clinical Practice - Overcoming Clinical Inertia
Jose Rubio, MD
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
CME/CEFrom Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
Jorge Plutzky, MD
Bradley Eilerman, MD, MHI
Industry Feature
Under the Radar: Diagnosing Hereditary ATTR Across Specialties
Medical Industry FeatureUnder the Radar: Diagnosing Hereditary ATTR Across Specialties
Jennifer Caudle, DO, FACOFP
Kevin Alexander, MD
Anasheh Halabi, MD, PhD
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
Redefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Medical Industry FeatureRedefining Durability in Wet AMD: Insights from the SOL‑1 Superiority Trial
Priya Vakharia, MD
Andrew Moshfeghi
Treatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Medical Industry FeatureTreatment Decisions in mCSPC: A Review of Retrospective Real-World Evidence
Jennifer Caudle, DO, FACOFP
Gregory McMahon, DO
Debunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Medical Industry FeatureDebunking Five Misconceptions in Agitation in Alzheimer’s Dementia
Clay Jackson, MD
Amita Patel, MD, CMD
Exploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Medical Industry FeatureExploring the Role of IgG Autoantibodies in Idiopathic Inflammatory Myopathies (IIM)
Brian P. McDonough, MD, FAAFP
Julie Paik, MD, MHS